Victory Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.55M Sell
56,281
-49,147
-47% -$1.36M ﹤0.01% 1665
2025
Q1
$2.99M Sell
105,428
-10,504
-9% -$298K ﹤0.01% 1433
2024
Q4
$4.82M Sell
115,932
-168,512
-59% -$7.01M ﹤0.01% 1274
2024
Q3
$19M Buy
284,444
+107
+0% +$7.15K 0.02% 859
2024
Q2
$33.8M Sell
284,337
-15,173
-5% -$1.8M 0.03% 597
2024
Q1
$31.9M Sell
299,510
-3,622
-1% -$386K 0.03% 645
2023
Q4
$30.1M Buy
303,132
+21,135
+7% +$2.1M 0.03% 619
2023
Q3
$29.1M Buy
281,997
+32,371
+13% +$3.34M 0.03% 608
2023
Q2
$30.3M Sell
249,626
-34,960
-12% -$4.25M 0.03% 603
2023
Q1
$43.7M Sell
284,586
-183,747
-39% -$28.2M 0.05% 486
2022
Q4
$84.1M Buy
468,333
+177,047
+61% +$31.8M 0.1% 268
2022
Q3
$34.4M Buy
291,286
+26,838
+10% +$3.17M 0.04% 601
2022
Q2
$37.8M Sell
264,448
-11,285
-4% -$1.61M 0.04% 571
2022
Q1
$37.1M Buy
275,733
+19,330
+8% +$2.6M 0.04% 649
2021
Q4
$65.1M Buy
256,403
+21,738
+9% +$5.52M 0.06% 455
2021
Q3
$90.3M Sell
234,665
-54,370
-19% -$20.9M 0.09% 310
2021
Q2
$67.9M Sell
289,035
-6,672
-2% -$1.57M 0.07% 424
2021
Q1
$38.7M Sell
295,707
-20,601
-7% -$2.7M 0.04% 656
2020
Q4
$33M Buy
316,308
+46,409
+17% +$4.85M 0.04% 675
2020
Q3
$19.1M Buy
269,899
+222,174
+466% +$15.7M 0.02% 819
2020
Q2
$3.06M Sell
47,725
-27,503
-37% -$1.77M ﹤0.01% 1303
2020
Q1
$2.25M Buy
75,228
+33,923
+82% +$1.02M ﹤0.01% 1548
2019
Q4
$808K Buy
41,305
+10,499
+34% +$205K ﹤0.01% 1807
2019
Q3
$490K Buy
+30,806
New +$490K ﹤0.01% 1893